Skip to content

Carbon-ion radiotherapy

RADIATION11 trials

Sponsors

Kasuya Goro, Tsuji Hiroshi, Wakatsuki Masaru, Ion Bean Therapy Center, SAGA HIMAT Foundation, Ion Beam Therapy Center, SAGA HIMAT Foundation

Conditions

ChordomaHepatocellular CarcinomaLocally Advanced Pancreatic CancerNasopharyngeal CarcinomaProstate CarcinomaProstate cancer Prostate cancerRenal cell carcinoma Metastatic renal cell carcinomaatrial fibrillation atrial fibrillation

Early Phase 1

Phase 2

A phase II clinical trial of carbon-ion radiotherapy for patients with bone and soft tissue sarcomas not suited for surgical resection(HIMAT1341)
RecruitingJPRN-UMIN000012373
Ion Bean Therapy Center, SAGA HIMAT Foundationbone and soft tissue sarcomas not suited for surgical resection
Start: 2013-12-01Target: 40Updated: 2026-06-29
A phase II clinical trial of carbon-ion radiotherapy for patients with local recurrence after primarily resected rectal cancer (HIMAT1351)
RecruitingJPRN-UMIN000013688
Ion Beam Therapy Center, SAGA HIMAT Foundationlocal recurrence after primarily resected rectal cancer
Start: 2014-04-11Target: 40Updated: 2026-06-29
Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma
WithdrawnNCT02946138
Shanghai Proton and Heavy Ion CenterHepatocellular Carcinoma
Start: 2016-10-31End: 2019-08-31Updated: 2019-09-09
A Phase II Clinical Trial of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer
Active, not recruitingJPRN-UMIN000030762
Kanagawa Cancer Center, Kanagawa Prefectural Hospital OrganizationLocally Advanced Pancreatic Cancer
Start: 2017-12-28Target: 77Updated: 2026-06-29
A Phase I/II clinical trial of Carbon-ion radiotherapy for patients with immune checkpoint inhibitor resistant metastatic renal cell carcinoma
Active, not recruitingJPRN-jRCT1032190111
Kasuya GoroRenal cell carcinoma Metastatic renal cell carcinoma
Start: 2019-10-07Target: 20Updated: 2026-06-29
Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma
NCT04143984
Shanghai Proton and Heavy Ion CenterNasopharyngeal Carcinoma
Start: 2021-01-19End: 2025-12-20Target: 146Updated: 2022-04-29
4fr.CIRT for high risk-prostate cancer + dose measurement
Active, not recruitingJPRN-jRCTs032190180
Tsuji HiroshiProstate cancer Prostate cancer
Start: 2020-04-07Target: 40Updated: 2026-06-29

Unknown Phase

Related Papers